Affordable Care Act and Health Outcomes of People Living with HIV in Virginia

平价医疗法案和弗吉尼亚州艾滋病毒感染者的健康结果

基本信息

  • 批准号:
    8983597
  • 负责人:
  • 金额:
    $ 6.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The Affordable Care Act (ACA) is federal legislature that aims to increase the number of people with health insurance and to improve health outcomes. People living with HIV (PLWH) are often uninsured or underinsured, and therefore are positioned to theoretically benefit from the ACA. Providing HIV medications to PLWH is beneficial to the individual for his longevity and to the public in terms of reduced HIV transmission. Before the ACA passage, state AIDS Drug Assistance Programs (ADAPs) were the safety net resource responsible for providing key medications, including antiretroviral therapy and opportunistic infection prophylaxis, to uninsured or underinsured PLWH. While called a safety net, state ADAPs serve over 193,000 PLWH nationally, and in 2013, it was estimated that about one-third of PLWH receiving HIV care accessed medications through ADAP. Approximately 80% of Virginia ADAP clients were eligible for ACA insurance plans, and with this opportunity, Virginia ADAP shifted its role to help enroll its clients in ACA insurance plans, and it is paying ACA monthly premiums, medication copayments, and deductibles, as this is the new avenue for its clients to receive key medications. The ACA needs to be examined to see how it is being implemented and to ensure that it is having its intended effects. Moreover, given that federal and state funding supports ADAP, it needs to be assessed whether good outcomes are achieved. This work will (1) characterize the demographic and systems-level differences between Virginia ADAP clients who were enrolled in ACA insurance plans and those who were eligible but were not enrolled during the 2013- 2014 enrollment process and (2) define the relationship between months enrolled in an ACA insurance plan and HIV outcomes. This research will utilize Virginia Department of Health statewide data to provide important information for state and federal policy. In addition to addressing these research aims, this fellowship will also include a rigorous training program of didactic course work and close research mentoring by senior health services researchers, health economists, clinical epidemiologists and biostatisticians. This NRSA fellowship training plan will allow me to advance as an investigator and successfully compete for a K series career development award. Findings about the implementation of ACA insurance enrollment and the ACA's effects on HIV outcomes will be significant contributions to the fields of health services research, health policy and HIV care. The research generated with this NRSA fellowship opportunity will inform state and federal level discussions of ACA enrollment and outcomes achieved with this new policy. In a time of constrained budgets, funds need to be allocated in a way to optimize enrollment and achieve the best health outcomes. Good HIV health outcomes have benefits to the individual as well as to society.
 描述(由申请人提供):《平价医疗法案》(ACA)是联邦立法机构,旨在增加拥有医疗保险的人数,改善健康状况。艾滋病毒感染者(PLWH)通常没有保险或保险不足,因此理论上可以从ACA中受益。向艾滋病毒携带者提供艾滋病毒药物,有利于个人长寿,也有利于公众减少艾滋病毒传播。在ACA通过之前,州艾滋病药物援助计划(ADAP)是负责向未投保或投保不足的PLWH提供关键药物的安全网资源,包括抗逆转录病毒治疗和机会性感染预防。虽然被称为安全网,但州ADAP在全国范围内为超过193,000名艾滋病毒感染者提供服务,据估计,2013年,约有三分之一接受艾滋病毒护理的艾滋病毒感染者通过ADAP获得药物。大约80%的弗吉尼亚州ADAP客户有资格获得ACA保险计划,有了这个机会,弗吉尼亚州ADAP转变了角色,帮助其客户参加ACA保险计划,它每月支付ACA保费,药物共付额和免赔额,因为这是其客户获得关键药物的新途径。需要对《反腐败法》进行审查,以了解其执行情况,并确保其产生预期效果。此外,鉴于联邦和州的资金支持ADAP,需要评估是否取得了良好的成果。这项工作将(1)描述参加ACA保险计划的弗吉尼亚州ADAP客户与那些符合条件但在2013- 2014年登记过程中未登记的客户之间的人口统计和系统级别差异,以及(2)定义参加ACA保险计划和艾滋病毒结果之间的关系。这项研究将利用弗吉尼亚州卫生部全州范围的数据,为州和联邦政策提供重要信息。除了解决这些研究目标外,该奖学金还将包括严格的教学课程培训计划,以及高级卫生服务研究人员,卫生经济学家,临床流行病学家和生物统计学家的密切研究指导。这个NRSA奖学金培训计划将使我能够作为一名调查员前进,并成功地竞争K系列职业发展奖。ACA保险的实施和ACA对艾滋病毒结果的影响的调查结果将是重大贡献的卫生服务研究,卫生政策和艾滋病护理领域。与此NRSA奖学金机会产生的研究将告知州和联邦一级的ACA入学和成果与这一新政策的讨论。在预算紧张的时期,需要以优化入学率和实现最佳健康结果的方式分配资金。良好的艾滋病毒健康结果对个人和社会都有好处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathleen Ann McManus其他文献

Kathleen Ann McManus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathleen Ann McManus', 18)}}的其他基金

Viral Suppression for People with HIV with Low Incomes: Study of Disparities, Health Equity, and Best Practices
低收入艾滋病毒感染者的病毒抑制:差异、健康公平和最佳实践的研究
  • 批准号:
    10619064
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and Mediators
解构艾滋病毒差异:数据、结果和中介因素的多州研究
  • 批准号:
    9763431
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and Mediators
解构艾滋病毒差异:数据、结果和中介因素的多州研究
  • 批准号:
    10231180
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and Mediators
解构艾滋病毒差异:数据、结果和中介因素的多州研究
  • 批准号:
    10455464
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
Deconstructing HIV Disparities: Multistate Study of Data, Outcomes and Mediators
解构艾滋病毒差异:数据、结果和中介因素的多州研究
  • 批准号:
    10685639
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:

相似国自然基金

CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
  • 批准号:
    CSTB2023NSCQ-MSX0916
  • 批准年份:
    2023
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
  • 批准号:
    U1903111
  • 批准年份:
    2019
  • 资助金额:
    57 万元
  • 项目类别:
    联合基金项目
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
  • 批准号:
    31201517
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Closing Racial Disparities Through the Affordable Care Act: Medicaid Expansion, Marketplaces, Federally Qualified Community Health Centers
通过《平价医疗法案》缩小种族差异:医疗补助扩张、市场、联邦合格的社区卫生中心
  • 批准号:
    10717603
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
The Effects of the Affordable Care Act Medicaid Expansion on Informal Care
《平价医疗法案》医疗补助扩展对非正式医疗的影响
  • 批准号:
    10351420
  • 财政年份:
    2022
  • 资助金额:
    $ 6.27万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10201216
  • 财政年份:
    2021
  • 资助金额:
    $ 6.27万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10359441
  • 财政年份:
    2021
  • 资助金额:
    $ 6.27万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10533828
  • 财政年份:
    2021
  • 资助金额:
    $ 6.27万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10360535
  • 财政年份:
    2021
  • 资助金额:
    $ 6.27万
  • 项目类别:
The Impact of the Affordable Care Act (ACA) on Unintended Pregnancy: Combining epidemiological and econometric methods.
《平价医疗法案 (ACA)》对意外怀孕的影响:结合流行病学和计量经济学方法。
  • 批准号:
    10254272
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
Effects of Affordable Care Act Medicaid Expansion on Disparities in Trauma Care and Outcomes in Young Adults
平价医疗法案医疗补助扩大对年轻人创伤护理和结果差异的影响
  • 批准号:
    9922388
  • 财政年份:
    2019
  • 资助金额:
    $ 6.27万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10296663
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10063448
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了